New global guidelines warn against obesity drugs for children under 10
Getty Images
Children under 10 should not be given obesity drugs or GLP-1 weight-loss injections such as Mounjaro and Wegovy,
<p>Dr Luz De Rigil, Director of <a for children under who does not recommend obesity medicines bariatric surgery or weight-management devices. this is a strong recommendation.>
These might be appropriate for older children and adolescents when <a mentally and physically prepared" for the treatment, she added.
She said WHO recognises this is an evolving field and will continue to evaluate the evidence.
WHO’s head of <a We are particularly concerned in this age group, if you are starting children very early on to using a GLP-1 or drugs like this, when does that stop?
“We don’t really have evidence that you can use this as a temporary treatment and then turn to something dietary later on in life.
“We are very cautious about jumping in without clear evidence,” he said.
